AVZIVI FDA approval date

The FDA approved AVZIVI on 6 Dec 2023.

FDA approval date
6 Dec 2023

Drug identity has not yet been verified against registry records

Also recorded as BEVACIZUMAB-TNJN

Included trials

No linked trials for this drug yet. Browse all trials

PDUFA dates and FDA decisions

Date as reportedDrug / companyEventConditionEvidence
2023-12-06DayAVZIVIFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "BLA761198", "applicant_as_listed_by_fda": "BIO-THERA SOLUTIONS LTD", "brand_names": ["AVZIVI"], "active_ingredients": ["BEVACIZUMAB-TNJN"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20231206", "matched_on": "drug record created from this FDA brand name"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026